TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/23 08:00 | 11/16/23 | RANI | Rani Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Nanavaty Maulik | CA | D | P | 1 | 1.98 | 0 | 1 | 5 | 12 | D | |||||||||||||||
3/2/22 16:28 | 2/28/22 | BSX | Boston Scientific Corp | DE | Health | MdEq | Surgical & Medical Instrument | Nanavaty Maulik | MA | O | SVP,P,Ne | M.d | 0 | 0.00 | 0 | 2 | 1 | 177 | D | ||||||||||||||
2/23/22 16:18 | 2/21/22 | BSX | Boston Scientific Corp | DE | Health | MdEq | Surgical & Medical Instrument | Nanavaty Maulik | MA | O | SVP,P,Ne | M.d | 0 | 0.00 | 0 | 2 | 1 | 176 | D | ||||||||||||||
2/22/22 16:46 | 2/17/22 | BSX | Boston Scientific Corp | DE | Health | MdEq | Surgical & Medical Instrument | Nanavaty Maulik | MA | O | SVP,P,Ne | M.dm | 0 | 0.00 | 0 | 4 | 2 | 175 | D | ||||||||||||||
2/17/22 20:28 | 2/15/22 | BSX | Boston Scientific Corp | DE | Health | MdEq | Surgical & Medical Instrument | Nanavaty Maulik | MA | O | SVP,P,Ne | M.d | 0 | 0.00 | 0 | 2 | 1 | 172 | D | ||||||||||||||
1/3/22 16:52 | 1/1/22 | BSX | Boston Scientific Corp | DE | Health | MdEq | Surgical & Medical Instrument | Nanavaty Maulik | MA | O | SVP,P,Ne | M.d | 0 | 0.00 | 0 | 6 | 4 | 171 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |